Chimerically Speaking Mohammad Alhomoud and Joshua Fein

What a delight to have Dr. Mariam Nawas of the University of Chicago join us for a round-up of her favorite abstracts from Tandem 2024! We also discussed her recent and controversial review "Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML", which appeared in Blood Advances earlier this year.
Hosted on Acast. See acast.com/privacy for more information.

Dr. Sam Yamshon, assistant professor of medicine at Weill Cornell Medicine at New York Presbyterian, joins us to chat about the most thought-provoking lymphoma CAR-T abstracts from #Tandem24.
Hosted on Acast. See acast.com/privacy for more information.

We're joined 'in the studio' by our very first interview guest, our good friend, the brilliant Dr. Kai Rejeski. Kai has been at the forefront of understanding hematologic toxicity of CAR-T therapies, and speaks with us about the HEMATOTOX score, ICAHT guidelines, and the excellent coffee in San Antonio.
Hosted on Acast. See acast.com/privacy for more information.

Welcome! This is the first episode of Chimerically Speaking. We're excited to share our love for the science and brilliant, creative community of transplantation and cellular therapy.
In this episode we'll talk about the upcoming Tandem 2024 meeting ahead of traveling to San Antonio this week. We highlight two abstracts (of so many!) that really caught our attention:
Al Malki and colleages, TSC-100/TSC-101 Ph. 1 https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/23846
Schoettler and colleagues, TA-TMA and age https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/22981

Hosted on Acast. See acast.com/privacy for more information.